JHP, headquartered in New Jersey, is a fully integrated specialty pharmaceutical company that acquires, develops, manufactures and sells sterile injectable products. JHP sells fourteen branded products primarily to hospitals, including Aplisol, used in diagnostic tests for tuberculosis; Dantrium, the only treatment for malignant hyperthermia; and Brevital, a fast-acting anesthetic. The company operates a high-quality sterile manufacturing facility in Rochester, Michigan and is focused on growing through developing and commercializing a portfolio of generic injectable drugs.
Warburg Pincus acquired JHP from Morgan Stanley Principal Investments in 2012, and injected additional growth capital to fund an expansion of the company’s development pipeline.
Back to Previous Page